JP2000514057A5 - - Google Patents

Download PDF

Info

Publication number
JP2000514057A5
JP2000514057A5 JP1998504146A JP50414698A JP2000514057A5 JP 2000514057 A5 JP2000514057 A5 JP 2000514057A5 JP 1998504146 A JP1998504146 A JP 1998504146A JP 50414698 A JP50414698 A JP 50414698A JP 2000514057 A5 JP2000514057 A5 JP 2000514057A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998504146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000514057A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/010120 external-priority patent/WO1998000113A1/en
Publication of JP2000514057A publication Critical patent/JP2000514057A/ja
Publication of JP2000514057A5 publication Critical patent/JP2000514057A5/ja
Ceased legal-status Critical Current

Links

JP10504146A 1996-06-28 1997-06-25 増強されたバイオアベイラビリティを有する抗真菌剤の固溶体 Ceased JP2000514057A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67270696A 1996-06-28 1996-06-28
US08/672,706 1996-06-28
PCT/US1997/010120 WO1998000113A1 (en) 1996-06-28 1997-06-25 Solid solution of an antifungal agent with enhanced bioavailability

Publications (2)

Publication Number Publication Date
JP2000514057A JP2000514057A (ja) 2000-10-24
JP2000514057A5 true JP2000514057A5 (enExample) 2005-02-10

Family

ID=24699673

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10504146A Ceased JP2000514057A (ja) 1996-06-28 1997-06-25 増強されたバイオアベイラビリティを有する抗真菌剤の固溶体

Country Status (7)

Country Link
EP (1) EP0954288B1 (enExample)
JP (1) JP2000514057A (enExample)
AT (1) ATE273002T1 (enExample)
AU (1) AU3483497A (enExample)
DE (1) DE69730241T2 (enExample)
ES (1) ES2224256T3 (enExample)
WO (1) WO1998000113A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
NZ504834A (en) * 1997-12-22 2001-12-21 Schering Corp Tricyclic amide molecular dispersion composition with enhanced bioavailability
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
JP5159012B2 (ja) 1999-12-23 2013-03-06 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 不良溶解性の薬物に対する改良された医薬組成物
GB0019296D0 (en) * 2000-08-07 2000-09-27 Nipa Lab Limited Treatment for part processed leather
ITMI20022748A1 (it) 2002-12-23 2004-06-24 Eurand Int Dispersioni solide stabilizzate di farmaco in un carrier organico e procedimento per la loro preparazione.
ITMI20032020A1 (it) 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
JP2010526848A (ja) * 2007-05-11 2010-08-05 エフ.ホフマン−ラ ロシュ アーゲー 難溶性薬物用の医薬組成物
JP2015531749A (ja) 2012-06-21 2015-11-05 メイン ファーマ インターナショナル プロプライエタリー リミテッドMayne Pharma International Pty.Ltd. イトラコナゾール組成物及び投与剤形、並びにその使用方法
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
US11058682B2 (en) 2015-08-08 2021-07-13 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EP3925601B1 (en) 2016-02-26 2024-07-17 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
US10702520B1 (en) 2019-01-29 2020-07-07 Slayback Pharma Llc Pharmaceutical compositions of posaconazole
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG43179A1 (en) * 1991-12-18 1997-10-17 Warner Lambert Co A process for the prepatation of a solid dispersion
DK0736030T3 (da) * 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2000501018A5 (enExample)
JP2000500076A5 (enExample)
JP2001503407A5 (enExample)
JP2000501324A5 (enExample)
JP2000511583A5 (enExample)
JP2000500055A5 (enExample)
JP2001507177A5 (enExample)
JP2000500026A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000500874A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2001502569A5 (enExample)
JP2001506363A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000500857A5 (enExample)